Fracture Incidence and Characterization in Patients on Osteoporosis Treatment: The ICARO Study

Abstract

The incidence of fractures during treatment with antiresorptive agents in a clinical setting is considerably higher than that observed in randomized clinical trials. Inadequate compliance to treatment and lack of supplementation of calcium and vitamin D are major determinants of this poor response.